PE20061141A1 - Imidazoles sustituidos con heterociclilamida - Google Patents
Imidazoles sustituidos con heterociclilamidaInfo
- Publication number
- PE20061141A1 PE20061141A1 PE2006000214A PE2006000214A PE20061141A1 PE 20061141 A1 PE20061141 A1 PE 20061141A1 PE 2006000214 A PE2006000214 A PE 2006000214A PE 2006000214 A PE2006000214 A PE 2006000214A PE 20061141 A1 PE20061141 A1 PE 20061141A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- trifluorometoxy
- piperazin
- imidazol
- carbonyl
- Prior art date
Links
- 150000002460 imidazoles Chemical group 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 5
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 abstract 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 3
- 239000004202 carbamide Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 1
- 206010011831 Cytomegalovirus infection Diseases 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical class F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 241000700586 Herpesviridae Species 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical class O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES EL GRUPO a, ENTRE OTROS; * REPRESENTA EL LUGAR DE UNION AL GRUPO CARBONILO; R2 ES ALQUILO C1-C6, ALCOXI C1-C6, HIDROXICARBONILO,TRIFLUOROMETILO, ENTRE OTROS ;R3 ES FENILO,TRIFLUOROMETOXI, DIFLUOROMETOXI, MONOFLUOROMETOXI, ENTRE OTROS; R4 ES FENILO O HETEROARILO DE 5 O 6 MIEMBROS, ENTRE OTROS; R6 Y R7 SON H, METILO, ETILO. SON COMPUESTOS PREFERIDOS N- {1-METIL-2-[(4-PIRIDIN-2-IL-PIPERAZIN-1-IL)CARBONIL]-1H-IMIDAZOL-4-IL} -N'-[4-(TRIFLUORO-METOXI)FENIL]UREA; N- (1-METIL-2-{[4-(5-METILPIRIDIN-2-IL)PIPERAZIN-1-IL]CARBONIL}-1H-IMIDAZOL-4-IL)-N'-[4-(TRIFLUOROMETOXI)FENIL]UREA; N- (2-{[4-5-CLOROPIRIDIN-2-IL)PIPERAZIN-1-IL]CARBONIL}-1ETIL-1H--IMIDAZOL-4-IL) -N'-[4-(TRIFLUOROMETOXI)FENIL]UREA. SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO PREPARACION. LOS COMPUESTOS DESCRITOS MUESTRAN UNA ACTIVIDAD ANTIVIRAL, FRENTE A REPRESENTANTES DEL GRUPO DEL DE LOS HERPES VIRIDAE Y SON UTILES PARA EL TRATAMIENTO DE INFECCIONES DE CITOMEGALOVIRUS, PACIENTES CON SIDA, PACIENTES INMUNOSUPRIMIDOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005008183A DE102005008183A1 (de) | 2005-02-23 | 2005-02-23 | Heterocyclylamid-substituierte Imidazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061141A1 true PE20061141A1 (es) | 2006-12-29 |
Family
ID=36675125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000214A PE20061141A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
| PE2010000032A PE20100233A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2010000032A PE20100233A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7919489B2 (es) |
| EP (1) | EP1853582B1 (es) |
| JP (1) | JP5208522B2 (es) |
| KR (1) | KR101276003B1 (es) |
| CN (1) | CN101128455B (es) |
| AR (1) | AR053141A1 (es) |
| AT (1) | ATE446292T1 (es) |
| AU (1) | AU2006218276C1 (es) |
| BR (1) | BRPI0607995B8 (es) |
| CA (1) | CA2598521C (es) |
| DE (2) | DE102005008183A1 (es) |
| DK (1) | DK1853582T3 (es) |
| ES (1) | ES2333249T3 (es) |
| GT (1) | GT200600077A (es) |
| HN (2) | HN2006007774A (es) |
| IL (1) | IL185050A (es) |
| MX (1) | MX2007010308A (es) |
| MY (1) | MY140543A (es) |
| NO (1) | NO338997B1 (es) |
| NZ (1) | NZ560811A (es) |
| PE (2) | PE20061141A1 (es) |
| PL (1) | PL1853582T3 (es) |
| PT (1) | PT1853582E (es) |
| RU (1) | RU2415851C2 (es) |
| TW (1) | TWI388553B (es) |
| UY (1) | UY29387A1 (es) |
| WO (1) | WO2006089664A2 (es) |
| ZA (1) | ZA200707412B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004015007A1 (de) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
| DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
| DE102011101446A1 (de) * | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
| DE102011113749A1 (de) * | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
| CN104610160A (zh) * | 2013-11-04 | 2015-05-13 | 南京大学 | 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用 |
| CN104016925B (zh) * | 2014-06-17 | 2016-03-30 | 遵义医学院 | 4-烷基咪唑-2-羧酸的合成方法 |
| EP3312170A4 (en) | 2015-06-22 | 2018-12-12 | Sumitomo Dainippon Pharma Co., Ltd. | 1,4-di-substituted imidazole derivative |
| JP6507976B2 (ja) * | 2015-09-30 | 2019-05-08 | 東レ株式会社 | イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法 |
| CN116120238B (zh) * | 2023-03-01 | 2023-09-22 | 山东梅奥华卫科技有限公司 | 一种咪唑衍生物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342501B1 (en) | 1994-02-25 | 2002-01-29 | The Regents Of The University Of Michigan | Pyrrolo[2,3-d] pyrimidines as antiviral agents |
| DE69826695T2 (de) * | 1997-05-23 | 2006-02-02 | Bayer Pharmaceuticals Corp., West Haven | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen |
| WO1999023091A1 (en) | 1997-11-03 | 1999-05-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds as anti-inflammatory agents |
| JP4525883B2 (ja) * | 1998-07-23 | 2010-08-18 | アステラス製薬株式会社 | イミダゾール化合物 |
| HUP0203405A2 (hu) | 1998-12-09 | 2003-02-28 | Wyeth | Szubsztituált fenilén-diamin-csoportot és heterociklikus karboxamidcsoportot hordozó herpeszvírus inhibitor hatású tiokarbamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
| DE10257358A1 (de) | 2002-12-09 | 2004-07-08 | Bayer Healthcare Ag | Substituierte Pyrrole |
| DE102004015007A1 (de) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
| KR20070011475A (ko) * | 2004-05-12 | 2007-01-24 | 쉐링 코포레이션 | Ｃｘｃｒ1 및 ｃｘｃｒ2 케모카인 길항제 |
| DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
-
2005
- 2005-02-23 DE DE102005008183A patent/DE102005008183A1/de not_active Ceased
-
2006
- 2006-02-14 MX MX2007010308A patent/MX2007010308A/es active IP Right Grant
- 2006-02-14 DE DE502006005182T patent/DE502006005182D1/de active Active
- 2006-02-14 AU AU2006218276A patent/AU2006218276C1/en not_active Ceased
- 2006-02-14 PT PT06706932T patent/PT1853582E/pt unknown
- 2006-02-14 DK DK06706932.8T patent/DK1853582T3/da active
- 2006-02-14 JP JP2007556526A patent/JP5208522B2/ja not_active Expired - Fee Related
- 2006-02-14 BR BRPI0607995A patent/BRPI0607995B8/pt not_active IP Right Cessation
- 2006-02-14 CA CA2598521A patent/CA2598521C/en not_active Expired - Fee Related
- 2006-02-14 ZA ZA200707412A patent/ZA200707412B/xx unknown
- 2006-02-14 RU RU2007135277/04A patent/RU2415851C2/ru active
- 2006-02-14 CN CN2006800056123A patent/CN101128455B/zh not_active Expired - Fee Related
- 2006-02-14 NZ NZ560811A patent/NZ560811A/en unknown
- 2006-02-14 PL PL06706932T patent/PL1853582T3/pl unknown
- 2006-02-14 AT AT06706932T patent/ATE446292T1/de active
- 2006-02-14 WO PCT/EP2006/001325 patent/WO2006089664A2/de not_active Ceased
- 2006-02-14 ES ES06706932T patent/ES2333249T3/es active Active
- 2006-02-14 KR KR1020077021862A patent/KR101276003B1/ko not_active Expired - Fee Related
- 2006-02-14 EP EP06706932A patent/EP1853582B1/de active Active
- 2006-02-16 GT GT200600077A patent/GT200600077A/es unknown
- 2006-02-20 UY UY29387A patent/UY29387A1/es not_active Application Discontinuation
- 2006-02-21 HN HN2006007774A patent/HN2006007774A/es unknown
- 2006-02-21 MY MYPI20060736A patent/MY140543A/en unknown
- 2006-02-22 TW TW095105843A patent/TWI388553B/zh not_active IP Right Cessation
- 2006-02-22 AR ARP060100637A patent/AR053141A1/es active IP Right Grant
- 2006-02-22 PE PE2006000214A patent/PE20061141A1/es active IP Right Grant
- 2006-02-22 PE PE2010000032A patent/PE20100233A1/es active IP Right Grant
-
2007
- 2007-08-06 IL IL185050A patent/IL185050A/en active IP Right Grant
- 2007-08-20 US US11/894,307 patent/US7919489B2/en not_active Expired - Fee Related
- 2007-09-19 NO NO20074780A patent/NO338997B1/no not_active IP Right Cessation
-
2010
- 2010-01-18 HN HN2010000128A patent/HN2010000128A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
| PE20120509A1 (es) | Derivados 9,9 difluoro-9h-fluoreno que tiene actividad antiviral | |
| RU2007148217A (ru) | Получение производных n-фенил-2-пиримидинамина | |
| PE20010482A1 (es) | Derivados de 3-ureido-pirazol y procedimiento para su preparacion | |
| PE20020354A1 (es) | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) | |
| RU2502730C2 (ru) | Сульфонамидные соединения и их применение | |
| MEP61208A (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
| RU2010106393A (ru) | Новые микробиоциды | |
| PE20120533A1 (es) | Inhibidores del virus de la hepatitis c | |
| PE20040155A1 (es) | Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen | |
| PE20061353A1 (es) | Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa | |
| RU2003127736A (ru) | Ингибитора металлопротеиназ | |
| RU2283835C3 (ru) | Производные гетероциклических соединений и лекарственные средства | |
| RU2008123839A (ru) | Соединение оксазола и фармацевтическая композиция | |
| RU2003127733A (ru) | Ингибиторы металлопротеиназ | |
| RU2003120512A (ru) | Активаторы изоиндолин-1-он-глюкокиназы | |
| PE20020846A1 (es) | Derivados de nicotinamida como inhibidores de las isoenzimas pde4 | |
| PE20060693A1 (es) | Nuevos derivados de trifluorometansulfonanilida oxamida eter | |
| PT1261602E (pt) | Derivados imidazol-2-carboxamida como inibidores de cinase raf | |
| CA2324418A1 (en) | Novel opiate compounds, methods of making and methods of use | |
| AR039226A2 (es) | Compuestos utiles como intermediarios de preparacion y procedimientos | |
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| HRP20080493T3 (hr) | Supstituirani kinolinski derivati kao mitotski inhibitori kinezina | |
| PE20061141A1 (es) | Imidazoles sustituidos con heterociclilamida | |
| SE0201194D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |